ECU
ONC

Eisler Capital (US)’s BeOne Medicines Ltd ONC Stock Holding History

Eisler Capital (US)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,657
Closed -$807K – 696
2024
Q2 		$807K Buy
5,657
+1,040
+23% +$160K 0.01% 519
2024
Q1 		$722K Buy
+4,617
New +$743K 0.02% 410

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Eisler Capital (US)'s ONC Position: Q3 2024 in Review

Eisler Capital (US) sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 5,657 shares — an estimated $807K sold.

Eisler Capital (US) first reported a position in ONC in Q1 2024 and held it in 2 quarters. The position peaked at $807K in Q2 2024. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Eisler Capital (US) reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 5,657 BeOne Medicines Ltd shares in Q3 2024, an estimated $807K.
  • Eisler Capital (US) first reported a position in BeOne Medicines Ltd in Q1 2024 and held it in 2 quarters.
  • Eisler Capital (US)'s BeOne Medicines Ltd position peaked at $807K in Q2 2024.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.